KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Gains from Sales and Divestitures (2025 - 2026)

Bionano Genomics recorded quarterly Gains from Sales and Divestitures of $360.0 in Q1 2026, down 79.31% quarter-over-quarter from $1740.0 in Q4 2025.

Bionano Genomics' Gains from Sales and Divestitures history runs 2 years deep, the most recent figure standing at $360.0 for Q1 2026.

  • In Q1 2026, Gains from Sales and Divestitures changed N/A year-over-year to $360.0; the TTM figure through Mar 2026 stood at $360.0 (changed N/A YoY), while the FY2025 annual figure was $1740.0, changed N/A from the prior year.
  • Gains from Sales and Divestitures came in at $360.0 for Q1 2026 at Bionano Genomics, down from $1740.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $1740.0 in Q4 2025 to a low of $360.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Bionano Genomics 14.92 Mn 539,417.67 3.25 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 360.00
Mar 31, 2026 360.00
Dec 31, 2025 1,740.00
Dec 31, 2025 1,740.00